Hester Biosciences consolidated net profit declines 20.33% in the March 2022 quarter

Sales decline 12.01% to Rs 56.47 crore

Net profit of Hester Biosciences declined 20.33% to Rs 7.72 crore in the quarter ended March 2022 as against Rs 9.69 crore during the previous quarter ended March 2021. Sales declined 12.01% to Rs 56.47 crore in the quarter ended March 2022 as against Rs 64.18 crore during the previous quarter ended March 2021.

For the full year,net profit rose 14.20% to Rs 39.32 crore in the year ended March 2022 as against Rs 34.43 crore during the previous year ended March 2021. Sales rose 9.65% to Rs 235.01 crore in the year ended March 2022 as against Rs 214.33 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales56.4764.18 -12 235.01214.33 10 OPM %18.2830.80 -25.5332.03 - PBDT16.4420.82 -21 70.0866.74 5 PBT11.3117.19 -34 53.5053.42 0 NP7.729.69 -20 39.3234.43 14

Powered by Capital Market - Live News